Quest Diagnostics NNN Investor Hub | Cap Rate Trends, Credit Rating Trends, Lease Terms & Due Diligence

Quest Diagnostics

Last Year Cap

6.4%

This Year Cap

6.7%

Cap Change

0.3%

Last Year Rating

BBB+

This Year Rating

BBB+

Rating Change

No change

Quest Diagnostics – NNN Cap Rate Trend

Cap Rate Trends

wdt_ID wdt_created_by wdt_created_at wdt_last_edited_by wdt_last_edited_at Tenant Year Cap Rate
5779 admin2 2026 04:17 AM admin2 2026 04:17 AM 7 Brew 2,020 6.5
5780 admin2 2026 04:17 AM admin2 2026 04:17 AM 7 Brew 2,021 6.3
5781 admin2 2026 04:17 AM admin2 2026 04:17 AM 7 Brew 2,022 6.0
5782 admin2 2026 04:17 AM admin2 2026 04:17 AM 7 Brew 2,023 6.3
5783 admin2 2026 04:17 AM admin2 2026 04:17 AM 7 Brew 2,024 6.6
5784 admin2 2026 04:17 AM admin2 2026 04:17 AM 7 Brew 2,025 6.6
Tenant Year Cap Rate

Credit (what net-lease buyers care about)

Credit Snapshot

Quest Diagnostics

Cap Rates NNN
Last Year 6.4%
This Year 6.7%
Change 0.3%
S&P Rating CREDIT
Last Year BBB+
This Year BBB+
Change No change

Quest Diagnostics Net Lease: Secure, Essential Investment

Quest Diagnostics is a nationally recognized diagnostic testing and laboratory services provider with a strong presence in the net lease market. This guide reviews Quest Diagnostics cap rates, lease terms, tenant profile, and key due diligence considerations for buyers and sellers.

Investors often target Quest Diagnostics assets for:

  • Stable Healthcare Demand
  • Essential Diagnostic Services
  • Long-Term Net Lease Structure
  • Attractive 1031 Exchange Compatibility

Quest Diagnostics properties require careful evaluation of rent escalations, remaining lease term, renewal options, landlord responsibilities, and local healthcare demographics before underwriting an acquisition.

Quest Diagnostics Properties for 1031 Exchange Buyers

Quest Diagnostics NNN properties often trade differently than traditional retail properties because they are purpose-built healthcare facilities. Buyers should carefully evaluate lease structure, remaining lease term, renewal options, landlord responsibilities, tenant performance, and building adaptability to understand long-term risk, financing potential, and investment returns.

Quest Diagnostics – Credit Trend (S&P vs Moody’s)

Tenant_Rating_Trend

wdt_ID wdt_created_by wdt_created_at wdt_last_edited_by wdt_last_edited_at TenantKey Tenant Year Moody SP Moody_Grade SP_Grade Moody_GradeRank SP_GradeRank
1 admin2 2025 03:43 PM admin2 2025 03:43 PM 7eleveninc 7-Eleven, Inc. 2022 Baa2 A Lower Medium Grade Upper Medium Grade 5 6
2 admin2 2025 03:43 PM admin2 2025 03:43 PM 7eleveninc 7-Eleven, Inc. 2023 Baa2 A Lower Medium Grade Upper Medium Grade 5 6
3 admin2 2025 03:43 PM admin2 2025 03:43 PM 7eleveninc 7-Eleven, Inc. 2024 Baa2 A Lower Medium Grade Upper Medium Grade 5 6
4 admin2 2025 03:43 PM admin2 2025 03:43 PM 7eleveninc 7-Eleven, Inc. 2025 Baa2 A Lower Medium Grade Upper Medium Grade 5 6
5 admin2 2025 03:43 PM admin2 2025 03:43 PM 99centsonlystoresllc 99 Cents Only Stores, LLC 2022 Caa2 CCC+ Substantial Risk Substantial Risk 2 2
TenantKey Tenant Year Moody SP Moody_Grade SP_Grade Moody_GradeRank SP_GradeRank

Quest Diagnostics Stock Price (NYSE: DGX)

Quest Diagnostics Investment Market Statistics

AVERAGE SALE PRICE

$2,950,000

BUILDING SIZE

2,500 – 6,000 SF

AVERAGE NOI

$172,000

LAND

0.50 – 1.25 Acres

$/SF RANGE

$350 – $650

LEASE TERM SHOWN

10 years

Quest Diagnostics Investor Snapshot (Quick Facts)

Origins & Growth (Past)

• Founded in 1967 as Metropolitan Pathology Laboratory
• Expanded through acquisitions and organic growth
• Built a nationwide laboratory network
• Established patient service centers across the U.S.
• Invested in advanced diagnostic technologies
• Leading U.S. diagnostic testing provider

Where Quest Diagnostics Stands Today

• Extensive U.S. laboratory network
• Leading diagnostic testing provider
• High daily patient testing volume
• Primarily corporate-operated laboratories
• Expanding digital health solutions
• Focus on operational efficiency and quality

Where Quest Diagnostics Stands Today

• Expanded digital healthcare
• Increased automation & efficiency
• Growth in at-home testing
• Stronger patient engagement
• Optimized laboratory network
• Focus on diagnostic services
• Benefiting from healthcare demand

Why investors buy Quest Diagnostics NNN Properties or Quest Diagnostics ground Lease Properties?

Pros (what buyers like)

  • Established healthcare tenant
    Nationally recognized diagnostic testing provider with a large U.S. footprint.
  • Essential healthcare services
    Laboratory testing generates consistent, needs-based patient demand.
  • Attractive real estate
    Many locations are positioned in high-traffic medical and retail corridors with strong visibility.
  • Attractive lease structures
    Long-term NNN or ground leases appeal to passive investors and 1031 exchange buyers.

Cons (what can bite you)

 

Find out more

Quest Diagnostics cap rate, Quest Diagnostics NNN properties, Quest Diagnostics ground lease, Quest Diagnostics investment properties, Quest Diagnostics net lease, Quest Diagnostics lease terms, Quest Diagnostics tenant credit, Quest Diagnostics real estate, laboratory property for sale, diagnostic testing real estate, healthcare net lease, medical office investment, single tenant healthcare, 1031 exchange property, Quest Diagnostics property for sale

Quest Diagnostics Background & History

Quest Diagnostics is one of the largest diagnostic testing and laboratory services providers in the United States. The company offers a broad range of laboratory testing, preventive health screening, and diagnostic information services for patients, physicians, hospitals, employers, and health plans.

Since its founding, Quest Diagnostics has built a nationwide network of laboratories and patient service centers through strategic acquisitions, organic expansion, and continued investment in advanced diagnostic technologies. The company continues to expand its digital capabilities, at-home testing solutions, and data-driven healthcare services.

As demand for preventive care, chronic disease management, and diagnostic testing continues to grow, Quest Diagnostics remains well positioned within the healthcare sector by providing essential services that generate recurring patient demand and long-term occupancy.

Why Quest Diagnostics Matters to NNN Investors

Quest Diagnostics operates one of the largest diagnostic laboratory networks in the United States. Its business model is built around essential healthcare services, recurring physician referrals, and patient visits, with many locations serving as critical healthcare infrastructure within their communities.

Many Quest Diagnostics patient service centers are located in medical office buildings, healthcare campuses, and high-traffic retail corridors with excellent accessibility. Continued investment in automation, digital health technologies, and laboratory efficiency supports long-term operational performance and patient convenience.

Because diagnostic testing is an essential component of modern healthcare, Quest Diagnostics has become a highly recognized healthcare tenant within the single-tenant net lease market.

What Buyers and Sellers Should Evaluate

For investors evaluating Quest Diagnostics NNN properties, a Quest Diagnostics net lease, or a Quest Diagnostics ground lease, the investment thesis is typically centered on tenant quality, lease structure, and the long-term value of healthcare real estate. Buyers should place significant emphasis on lease economics, remaining lease term, rent escalations, and the quality of the underlying real estate.

Common searches include Quest Diagnostics real estate, Quest Diagnostics cap rate, Quest Diagnostics lease term, Quest Diagnostics tenant credit, and laboratory investment properties. Ultimately, Quest Diagnostics investment value is driven by lease structure, tenant performance, property fundamentals, and local healthcare demand.

Because laboratory facilities often include specialized medical improvements, investors should evaluate building adaptability, landlord responsibilities, visibility, surrounding demographics, referral networks, competition, and the potential costs of re-tenanting if the property becomes vacant.

In addition, buyers should consider long-term cash flow durability, demographic trends, healthcare utilization, and exit strategy when underwriting a Quest Diagnostics investment property.

our team of experts are here for you

Our team helps investors evaluate NNN properties with practical, market-based guidance. In addition, we support buyers and sellers with lease review, pricing analysis, and due diligence strategy.

Whether you are comparing Quest Diagnostics ground lease properties or fee simple Quest Diagnostics assets, we can help you review the details that affect risk and long-term value. As a result, clients can make more confident decisions based on lease structure, location quality, and investment goals.

Scroll to Top